What is the duration of action for intermediate insulin?

Intermediate insulin typically has a duration of action ranging from approximately 18 to 24 hours. This type of insulin, such as NPH (Neutral Protamine Hagedorn), is designed to provide a more sustained release of insulin compared to short-acting insulins, making it effective for managing blood glucose levels over a longer period.

Understanding its duration is crucial for patients who are managing diabetes, as it helps with planning meals and maintaining appropriate blood sugar levels throughout the day. Proper timing and dosing are essential to avoid potential complications related to hyperglycemia or hypoglycemia, ensuring that insulin therapy is safe and effective for individuals with diabetes.

The other options do not accurately reflect the pharmacokinetics of intermediate insulin, as they suggest durations that either fall short or extend beyond what is generally supported by clinical guidelines and pharmacological data.